Gene · 923
Papers1,942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study. | Sci Rep | 2024 | 39390078 | PubTator, text mining | PubMed |
| AP-1B regulates interactions of epithelial cells and intraepithelial lymphocytes in the intestine. | Cell Mol Life Sci | 2024 | 39369131 | PubTator, text mining | PubMed |
| The 1400 metabolite-mediated relationship between 91 inflammatory cytokines and migraine: An exploratory two-step Mendelian randomization study. | Eur J Clin Invest | 2024 | 39279254 | PubTator, text mining | PubMed |
| Evaluation of inflammatory biomarkers and their association with anti-SARS-CoV-2 antibody titers in healthcare workers vaccinated with BNT162B2. | Front Immunol | 2024 | 39247198 | PubTator, text mining | PubMed |
| Plasma proteomic signature of neonates in the context of placental histological chorioamnionitis. | BMJ Paediatr Open | 2024 | 39237269 | PubTator, text mining | PubMed |
| Genetic susceptibility to temporomandibular joint involvement in juvenile idiopathic arthritis. | J Oral Rehabil | 2024 | 39192486 | PubTator, text mining | PubMed |
| The causal relationship between autoimmune diseases and rhinosinusitis, and the mediating role of inflammatory proteins: a Mendelian randomization study. | Exp Biol Med (Maywood) | 2024 | 39104791 | PubTator, text mining | PubMed |
| Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study. | Clin Lymphoma Myeloma Leuk | 2024 | 39089930 | PubTator, text mining | PubMed |
| Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization. | Front Immunol | 2024 | 39076981 | PubTator, text mining | PubMed |
| Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity. | Front Immunol | 2024 | 39026665 | PubTator, text mining | PubMed |
| Identification of State Markers in Anorexia Nervosa: Replication and Extension of Inflammation-Associated Biomarkers Using Multiplex Profiling. | Biol Psychiatry Glob Open Sci | 2024 | 38989135 | PubTator, text mining | PubMed |
| Effects of circulating inflammatory proteins on spinal degenerative diseases: Evidence from genetic correlations and Mendelian randomization study. | JOR Spine | 2024 | 38895179 | PubTator, text mining | PubMed |
| ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors. | Oncoimmunology | 2024 | 38887373 | PubTator, text mining | PubMed |
| The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling. | Cell Commun Signal | 2024 | 38790044 | PubTator, text mining | PubMed |
| Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study. | Int Urol Nephrol | 2024 | 38776057 | PubTator, text mining | PubMed |
| Long-term therapy with itolizumab is safe and effective for patients with moderate to severe psoriasis: Results from an expanded-access program. | Int Immunopharmacol | 2024 | 38759368 | PubTator, text mining | PubMed |
| [Phenotyping and genotyping in patients with inflammatory bowel disease in a reference center in Colombia]. | Rev Gastroenterol Peru | 2024 | 38734909 | PubTator, text mining | PubMed |
| Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer. | Cancer Genomics Proteomics | 2024 | 38670590 | PubTator, text mining | PubMed |
| The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation. | J Autoimmun | 2024 | 38642507 | PubTator, text mining | PubMed |
| Recombinant CD5 and CD6 Ectodomains Induce Antiparasitic and Immunomodulatory Effects in Secondary Cystic Echinococcosis. | Parasite Immunol | 2024 | 38625016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/923/papers?page=6